Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clozapine for Cannabis Use Disorder in Schizophrenia
NCT01639872Phase 4Completed
- Sponsor
- Dartmouth Health
- Start
- May 2013
- Primary completion
- Mar 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of clozapine in cannabis use disorder (CUD), sponsored by Dartmouth Health. Started May 2013; status: completed.
02
Drugs
clozapine
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT01639872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01639872.